To strengthen its network and make the monitoring of the drug prices better, the National Pharmaceutical Pricing Authority (NPPA) has finally decided to go ahead with its plan to set up price modulating cell in each of the state drug control departments. To deliberate on this matter the NPPA recently had a meeting with all the state drug controllers in Delhi.
It is understood that as per the proposal, the NPPA plans to set up a dedicated cell within the office of each of the state drug departments. While the expenditure related to manpower, amenities and other infrastructural cost will be borne by the NPPA, state government will have to provide the space for setting up the office within the state drug regulatory office.
Under the proposed scheme, the cell is to be headed by one person along with a team of NPPA officials whose strength will vary as per the size of the pharma industry in respective states. A highly placed source informs that the NPPA has categorised the states based on three categories, i.e. based on maximum, minimum and least number of pharma cos in the state for better division of work.
They will be responsible to closely work with the state drug regulators to find out any discrepancies that affect the consumers. The officials heading the cell will be required to report their findings to the NPPA directly in case they find any pharma cos violating the law by selling the drugs above the ceiling price. According to a highly placed source, the NPPA plans to go ahead with this project on a phased manner and hopes to get the required clearance from the centre at the earliest.
http://www.pharmabiz.com/NewsDetails.aspx?aid=83867&sid=1
It is understood that as per the proposal, the NPPA plans to set up a dedicated cell within the office of each of the state drug departments. While the expenditure related to manpower, amenities and other infrastructural cost will be borne by the NPPA, state government will have to provide the space for setting up the office within the state drug regulatory office.
Under the proposed scheme, the cell is to be headed by one person along with a team of NPPA officials whose strength will vary as per the size of the pharma industry in respective states. A highly placed source informs that the NPPA has categorised the states based on three categories, i.e. based on maximum, minimum and least number of pharma cos in the state for better division of work.
They will be responsible to closely work with the state drug regulators to find out any discrepancies that affect the consumers. The officials heading the cell will be required to report their findings to the NPPA directly in case they find any pharma cos violating the law by selling the drugs above the ceiling price. According to a highly placed source, the NPPA plans to go ahead with this project on a phased manner and hopes to get the required clearance from the centre at the earliest.
http://www.pharmabiz.com/NewsDetails.aspx?aid=83867&sid=1
No comments:
Post a Comment